Massachusetts Financial Services
PRAX icon

Massachusetts Financial Services’s Praxis Precision Medicines PRAX Stock Holding History

Massachusetts Financial Services’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36M Buy
107,409
+100,021
+1,354% +$31.7M 0.01% 561
2026
Q1 		$2.38M Buy
7,388
+4,072
+123% +$1.26M ﹤0.01% 794
2025
Q4 		$977K Buy
+3,316
New +$618K ﹤0.01% 834

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Massachusetts Financial Services's PRAX Position: Q2 2026 in Review

Massachusetts Financial Services increased its Praxis Precision Medicines (PRAX) stake by 1,354% in Q2 2026, buying an estimated $31.7M and bringing the position to 107,409 shares worth $36M. The position accounts for 0.01% of the portfolio, ranked #561.

Massachusetts Financial Services first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 86 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Massachusetts Financial Services held 107,409 shares of Praxis Precision Medicines worth $36M as of Q2 2026.
  • Massachusetts Financial Services bought 100,021 Praxis Precision Medicines shares in Q2 2026, an estimated $31.7M.
  • Praxis Precision Medicines made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #561 holding.
  • Massachusetts Financial Services first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 86 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.